BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Gastroenterol. May 7, 2026; 32(17): 117479
Published online May 7, 2026. doi: 10.3748/wjg.v32.i17.117479
Table 1 Baseline characteristics of the included patients, mean ± SD/n (%)

Acute PVT (n = 46)
Chronic PVT (n = 59)
Cavernous transformation (n = 22)
Mixed PVT (n = 44)
Age (years)45.2 ± 5.947.8 ± 4.245.4 ± 4.348.4 ± 3.6
Gender
Male33 (71.7)42 (71.2)17 (77.3)32 (72.7)
Female13 (28.3)17 (28.8)5 (22.7)12 (27.3)
Background disease
HBV cirrhosis24 (52.2)29 (49.2)7 (31.8)20 (45.5)
HCV cirrhosis0 (0)1 (1.7)1 (4.5)0 (0)
ALC10 (21.7)13 (22.0)5 (22.7)7 (15.9)
PBC2 (4.3)3 (5.1)0 (0)2 (4.5)
AIC2 (4.3)6 (10.2)1 (4.5)1 (2.3)
BCS3 (6.5)5 (8.5)1 (4.5)3 (6.8)
HVOD1 (2.2)2 (3.4)1 (4.5)2 (4.5)
Unknown cause4 (8.7)0 (0)6 (27.3)9 (20.5)
Clinical symptoms
Abdominal pain10 (21.7)10 (17.0)0 (0)6 (13.6)
Variceal bleeding12 (26.1)21 (35.6)8 (36.4)15 (34.1)
Refractory ascites15 (32.6)11 (18.6)5 (22.7)14 (31.8)
Both above5 (10.9)13 (22.0)8 (36.4)7 (15.9)
Intestinal necrosis0 (0.0)2 (3.4)1 (4.5)1 (2.3)
Severe jaundice4 (8.7)2 (3.4)0 (0)1 (2.3)
Child-Pugh grade
Child A17 (37.0)21 (35.6)10 (45.5)16 (36.4)
Child B21 (45.6)26 (44.1)10 (45.5)19 (43.2)
Child C8 (17.4)12 (20.3)2 (9.1)9 (20.4)
Pre-PPG (mmHg)24.76 ± 5.6922.73 ± 6.7021.05 ± 5.6524.63 ± 6.23
Post-PPG (mmHg)12.88 ± 3.2418.26 ± 5.5714.07 ± 4.0417.72 ± 4.48


Write to the Help Desk